|
Volumn 47, Issue 3, 2001, Pages 187-198
|
Novel mechanism of cellular DNA topoisomerase II inhibition by the pyranonaphthoquinone derivatives α-lapachone and β-lapachone
|
Author keywords
Catalytic inhibitors; DNA topoisomerase II; Naphthoquinones
|
Indexed keywords
1,4 NAPHTHOQUINONE DERIVATIVE;
ALPHA LAPACHONE;
ANTIOXIDANT;
BETA LAPACHONE;
DNA TOPOISOMERASE (ATP HYDROLYSING);
DOUBLE STRANDED DNA;
ENDONUCLEASE;
PYRANONAPHTHOQUINONE DERIVATIVE;
UNCLASSIFIED DRUG;
ALPHA-LAPACHONE;
BETA-LAPACHONE;
ENZYME INHIBITOR;
ETOPOSIDE;
NAPHTHOQUINONE;
NUCLEIC ACID SYNTHESIS INHIBITOR;
ARTICLE;
CANCER CELL CULTURE;
CATALYSIS;
CONTROLLED STUDY;
DRUG MECHANISM;
DRUG SENSITIVITY;
DRUG STRUCTURE;
DRUG TARGETING;
ENZYME INHIBITION;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
MOLECULAR WEIGHT;
MULTIDRUG RESISTANCE;
NASOPHARYNX TUMOR;
OXIDATION;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
REDUCTION;
CELL CULTURE;
CLONOGENIC ASSAY;
DNA DAMAGE;
DRUG ANTAGONISM;
DRUG EFFECT;
ENZYME ACTIVATION;
OXIDATIVE STRESS;
PHYSIOLOGY;
COLONY-FORMING UNITS ASSAY;
DNA DAMAGE;
DNA TOPOISOMERASES, TYPE II;
ENZYME ACTIVATION;
ENZYME INHIBITORS;
ETOPOSIDE;
NAPHTHOQUINONES;
NUCLEIC ACID SYNTHESIS INHIBITORS;
OXIDATIVE STRESS;
TUMOR CELLS, CULTURED;
|
EID: 0034743360
PISSN: 03445704
EISSN: None
Source Type: Journal
DOI: 10.1007/s002800000221 Document Type: Article |
Times cited : (61)
|
References (33)
|